{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:11:45Z","timestamp":1759011105145,"version":"3.44.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jinf.2020.05.055","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T02:31:03Z","timestamp":1590546663000},"page":"289-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cost effectiveness of testing HIV infected individuals for TB in a low TB\/HIV setting"],"prefix":"10.1016","volume":"81","author":[{"given":"Santino J","family":"Capocci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janey","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Cropley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Bhagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelita","family":"Solamalai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Abubakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc C I","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2020.05.055_bib0001","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection","volume":"320","author":"Selwyn","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2020.05.055_bib0002","doi-asserted-by":"crossref","unstructured":"Akolo C., Adetifa I., Shepperd S., Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev2010(1):CD000171.","DOI":"10.1002\/14651858.CD000171.pub3"},{"key":"10.1016\/j.jinf.2020.05.055_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001270","article-title":"Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis","volume":"9","author":"Suthar","year":"2012","journal-title":"PLoS Med."},{"key":"10.1016\/j.jinf.2020.05.055_bib0004","unstructured":"European AIDS Clinical Society (EACS)guidelines 9.0; October2017. url:http:\/\/www.eacsociety.org\/files\/guidelines_9.0-english.pdf. Accessed 21 January 2018."},{"issue":"RR\u20134","key":"10.1016\/j.jinf.2020.05.055_bib0005","first-page":"1","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jinf.2020.05.055_bib0006","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1468-1293.2011.00954.x","article-title":"BHIVA Guidelines Subcommittee. British HIV Association guidelines for the treatment of TB\/HIV coinfection 2011","volume":"12","author":"Pozniak","year":"2011","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2020.05.055_bib0007","first-page":"1","article-title":"Tuberculosis - Clinical diagnosis and management of tuberculosis, and measures for its prevention and control","volume":"117","year":"2011","journal-title":"NICE Clin Guidel"},{"first-page":"1","year":"2016","series-title":"NG33 Tuberculosis: prevention, diagnosis, management and service organisation","key":"10.1016\/j.jinf.2020.05.055_bib0008"},{"issue":"6","key":"10.1016\/j.jinf.2020.05.055_bib0009","first-page":"s2","article-title":"British HIV Association Guidelines for the management of tuberculosis in adults living with HIV 2019","volume":"20","author":"Bracchi","year":"2019","journal-title":"HIV Med"},{"key":"10.1016\/j.jinf.2020.05.055_bib0010","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J"},{"year":"2014","series-title":"Tuberculosis in the UK: 2014 report","key":"10.1016\/j.jinf.2020.05.055_bib0011"},{"key":"10.1016\/j.jinf.2020.05.055_bib0012","doi-asserted-by":"crossref","unstructured":"Zenner D., Abubakar I., Conti S., Gupta R.K., Yin Z., Kall M., et al. Impact of TB on the survival of people living with HIV infection in England, Wales and Northern Ireland. Thorax2015;70:566\u201373.","DOI":"10.1136\/thoraxjnl-2014-206452"},{"key":"10.1016\/j.jinf.2020.05.055_bib0013","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1086\/510080","article-title":"Swiss HIV Cohort Study. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission","volume":"44","author":"Elzi","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.05.055_bib0014","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1097\/QAD.0b013e3283320dfd","article-title":"United Kingdom Collaborative HIV Cohort Study Group. Tuberculosis among people with HIV infection in the United Kingdom: Opportunities for prevention?","volume":"23","author":"Grant","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2020.05.055_bib0015","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1016\/S2352-3018(15)00063-6","article-title":"Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern Ireland","volume":"2","author":"Gupta","year":"2015","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jinf.2020.05.055_bib0016","unstructured":"World Health Organisation (WHO). Latent tuberculosis infection. Updated and consolidated guidelines for programmatic management. February2018. From:https:\/\/apps.who.int\/"},{"key":"10.1016\/j.jinf.2020.05.055_bib0017","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1186\/s12889-016-3539-2","article-title":"Intention of physicians to implement guidelines for screening and treatment of latent tuberculosis infection in HIV-infected patients in the Netherlands: a mixed-method design","volume":"16","author":"Evenblij","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jinf.2020.05.055_bib0018","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/thoraxjnl-2016-209063","article-title":"Latent tuberculosis infection screening and treatment in HIV: insights from evaluation of UK practice","volume":"72","author":"White","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2020.05.055_bib0019","unstructured":"World Health Organization (WHO)estimates of tuberculosis incidence by country, 2014. from:https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/491527\/WHO_estimates_of_tuberculosis_incidence_by_country__2014_v2.pdf; accessed June 18, 2016"},{"key":"10.1016\/j.jinf.2020.05.055_bib0020","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jinf.2020.05.055_bib0021","unstructured":"Oxford Immunotec. T-Spot.TB package insert. Abingdon, Oxford, United Kingdom."},{"key":"10.1016\/j.jinf.2020.05.055_bib0022","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1183\/09031936.00170913","article-title":"6-year follow-up of 522 HIV-positive individuals screened for Mycobacterium tuberculosis infection in Denmark","volume":"44","author":"Soborg","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2020.05.055_bib0023","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1086\/597351","article-title":"Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals","volume":"48","author":"Aichelburg","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.05.055_bib0024","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-\u03b3 release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2020.05.055_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2466-10-7","article-title":"Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis","volume":"10","author":"Pooran","year":"2010","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jinf.2020.05.055_bib0026","unstructured":"Curtis, L.Personal Social Services Research Unity, University of Kent. Unit Costs of Health and Social Care2019. From:https:\/\/www.pssru.ac.uk\/project-pages\/unit-costs\/unit-costs-2019\/, Supplement V, Table 15.3, p154. Accessed 30 April 2020"},{"article-title":"Guide to the methods of technology appraisal","year":"2008","series-title":"Guide to the Methods of Technology Appraisal 2008","key":"10.1016\/j.jinf.2020.05.055_bib0027"},{"key":"10.1016\/j.jinf.2020.05.055_bib0028","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.compbiomed.2018.05.009","article-title":"Mobile phone-based evaluation of latent tuberculosis infection: proof of concept for an integrated image capture and analysis system","volume":"98","author":"Naraghi","year":"2018","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jinf.2020.05.055_bib0029","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2334-12-107","article-title":"Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study","volume":"12","author":"Kall","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2020.05.055_bib0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-7-56","article-title":"Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test","volume":"7","author":"Brock","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.jinf.2020.05.055_bib0031","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness\u2013the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2020.05.055_bib0032","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(14)62335-7","article-title":"Shortage of purified protein derivative for tuberculosis testing","volume":"384","author":"Tebruegge","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2020.05.055_bib0033","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00042560-199604150-00005","article-title":"Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection","volume":"11","author":"Chaisson","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.jinf.2020.05.055_bib0034","doi-asserted-by":"crossref","first-page":"e53330","DOI":"10.1371\/journal.pone.0053330","article-title":"Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country","volume":"8","author":"Cheallaigh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2020.05.055_bib0035","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s12879-014-0667-0","article-title":"HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study","volume":"14","author":"Pullar","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2020.05.055_bib0036","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-119-3-199308010-00003","article-title":"Risk for developing tuberculosis among anergic patients infected with HIV","volume":"119","author":"Moreno","year":"1993","journal-title":"Ann Intern Med"},{"year":"2015","series-title":"Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV","key":"10.1016\/j.jinf.2020.05.055_bib0037"},{"key":"10.1016\/j.jinf.2020.05.055_bib0038","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1183\/09031936.00067114","article-title":"Decreasing cost effectiveness of testing for latent TB in HIV in a low TB incidence area","volume":"46","author":"Capocci","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2020.05.055_bib0039","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/cid\/ciz252","article-title":"Blood transcriptomic stratification of short-term risk in contacts of tuberculosis","volume":"70","author":"Roe","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.05.055_bib0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/cid\/ciy835","article-title":"A Novel, 5-Transcript, whole-blood gene-expression signature for tuberculosis screening among people living with human immunodeficiency virus","volume":"69","author":"Ranjan","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.05.055_bib0041","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/QAD.0b013e32835e2cb1","article-title":"Decreasing incidence of tuberculosis among heterosexuals living with diagnosed HIV in England and Wales","volume":"27","author":"Rice","year":"2013","journal-title":"AIDS"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320303327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320303327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:29:44Z","timestamp":1759008584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445320303327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0163445320303327"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2020.05.055","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost effectiveness of testing HIV infected individuals for TB in a low TB\/HIV setting","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2020.05.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}